Novel Approach for Microbiome Analysis Using Bacterial Replication Rates and Causal Inference with Applications

Motivation Metagenomics sequencing data can be used to compute not just the relative abundance profile, but also the replication rates of every taxon in the microbiome sample. We investigate how the dynamics implied by the replication rates can be used to understand the antibiotic response in microbiomes, given the significant variation in the types of antibiotics and the types of response by different taxa. The analysis is further expanded by factoring in the resistome of the microbiomes, which can be readily profiled from the metagenomic sequence data. The fact that some antibiotics such as β-lactams target replicating cells makes it even more critical to use replication rates to analyze the antibiotic response. Results We introduce a novel approach for metagenomic analysis that integrates microbial community profiling, replication rate calculation, and causal structural learning to analyze the antibiotic response. First, we developed PeTRi, which involves efficient cluster computation of bacterial replication rates from metagenomic sequence data. Second, we integrate the abundance profile, replication profile, resistome profile, and environmental variables to perform causality analysis. Finally, we applied the integrated analysis to the data from an infant gut microbiome study. Conclusions from our analysis are as follows: (i) Microbes tend to lower their replication rates in response to β-lactams; (ii) The presence of antibiotic resistance genes combined with the causality analysis strongly suggest that genes fosA5, oqxA, kpnF, arnA, and acrA provides resistance for the taxon K. pneumoniae, allowing it to replicate and dominate the microbiome after the drug ticarcillin-clavulanate was administered; and (iii) Human and donor milk strongly influence the resistome of the infant gut microbiome. Availability The pipeline for calculation of bacterial replication rates using the high performance computing framework Slurm is available from https://biorg.cs.fiu.edu/petri/.

[1]  Julia Oh,et al.  Metagenomic growth rate inferences of strains in situ , 2020, Science Advances.

[2]  Kalai Mathee,et al.  Causal Inference in Microbiomes Using Intervention Calculus , 2020, bioRxiv.

[3]  Giri Narasimhan,et al.  Inferring directional relationships in microbial communities using signed Bayesian networks , 2020, BMC Genomics.

[4]  Geoffrey L. Winsor,et al.  CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database , 2019, Nucleic Acids Res..

[5]  Giri Narasimhan,et al.  So you think you can PLS-DA? , 2017, BMC Bioinformatics.

[6]  I. Csabai,et al.  Raw milk for human consumption may carry antimicrobial resistance genes , 2019, bioRxiv.

[7]  Anne-Florence Bitbol,et al.  Resist or perish: Fate of a microbial population subjected to a periodic presence of antimicrobial , 2019, bioRxiv.

[8]  Antibiotic resistance threats in the United States, 2019 , 2019 .

[9]  E. Lefkowitz,et al.  Individualized recovery of gut microbial strains post antibiotics , 2019, npj Biofilms and Microbiomes.

[10]  Jennifer Lu,et al.  Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.

[11]  A. Buckling,et al.  Resident microbial communities inhibit growth and antibiotic resistance evolution of Escherichia coli in human gut microbiome samples , 2019, bioRxiv.

[12]  Camilo Valdes,et al.  Large scale microbiome profiling in the cloud , 2019, Bioinform..

[13]  J. Daniels,et al.  Carbapenemase-producing Enterobacteriaceae and Aeromonas spp. present in wastewater treatment plant effluent and nearby surface waters in the US , 2019, PloS one.

[14]  P. Spirtes,et al.  Review of Causal Discovery Methods Based on Graphical Models , 2019, Front. Genet..

[15]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[16]  Emmanuel Paradis,et al.  ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R , 2018, Bioinform..

[17]  Hongzhe Li,et al.  Quantifying and comparing bacterial growth dynamics in multiple metagenomic samples , 2018, Nature Methods.

[18]  Julia Oh,et al.  High throughput in situ metagenomic measurement of bacterial replication at ultra-low sequencing coverage , 2018, Nature Communications.

[19]  Giri Narasimhan,et al.  Inferring Relationships in Microbiomes from Signed Bayesian Networks , 2018, 2018 IEEE 8th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS).

[20]  Giri Narasimhan,et al.  Dynamic interaction network inference from longitudinal microbiome data , 2018, Microbiome.

[21]  Brian C. Thomas,et al.  Hospitalized Premature Infants Are Colonized by Related Bacterial Strains with Distinct Proteomic Profiles , 2017, mBio.

[22]  J. Banfield,et al.  Machine Learning Leveraging Genomes from Metagenomes Identifies Influential Antibiotic Resistance Genes in the Infant Gut Microbiome , 2017, mSystems.

[23]  Daniel J. Wilson,et al.  The distribution of bacterial doubling times in the wild , 2017, bioRxiv.

[24]  Kim-Anh Lê Cao,et al.  mixOmics: An R package for ‘omics feature selection and multiple data integration , 2017, bioRxiv.

[25]  L. Silver Fosfomycin: Mechanism and Resistance. , 2017, Cold Spring Harbor perspectives in medicine.

[26]  Brian C. Thomas,et al.  Identical bacterial populations colonize premature infant gut, skin, and oral microbiomes and exhibit different in situ growth rates. , 2017, Genome Research.

[27]  A. Chmielarczyk,et al.  Klebsiella pneumoniae in Breast Milk-A Cause of Sepsis in Neonate , 2017 .

[28]  Brian C. Thomas,et al.  Measurement of bacterial replication rates in microbial communities , 2016, Nature Biotechnology.

[29]  H. Nair,et al.  Global disease burden due to antibiotic resistance – state of the evidence , 2016, Journal of global health.

[30]  Molly K. Gibson,et al.  Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome , 2016, Nature Microbiology.

[31]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[32]  M. Campos,et al.  Microbial "social networks" , 2015, BMC Genomics.

[33]  H. B. Tokman,et al.  The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey. , 2015, Anaerobe.

[34]  Eran Segal,et al.  Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples , 2015, Science.

[35]  P. Ray,et al.  Intestinal colonization among very low birth weight infants in first week of life , 2014, Indian Pediatrics.

[36]  E. Pamer,et al.  Enterococci and Their Interactions with the Intestinal Microbiome , 2014, Microbiology spectrum.

[37]  Marco Scutari,et al.  Bayesian Network Constraint-Based Structure Learning Algorithms: Parallel and Optimised Implementations in the bnlearn R Package , 2014, ArXiv.

[38]  Jean-Baptiste Denis,et al.  Bayesian Networks , 2014 .

[39]  N. Chauhan,et al.  Role of Novel Multidrug Efflux Pump Involved in Drug Resistance in Klebsiella pneumoniae , 2014, PloS one.

[40]  Diego Colombo,et al.  Order-independent constraint-based causal structure learning , 2012, J. Mach. Learn. Res..

[41]  Derrick E. Wood,et al.  Kraken: ultrafast metagenomic sequence classification using exact alignments , 2014, Genome Biology.

[42]  V. Srinivasan,et al.  KpnEF, a New Member of the Klebsiella pneumoniae Cell Envelope Stress Response Regulon, Is an SMR-Type Efflux Pump Involved in Broad-Spectrum Antimicrobial Resistance , 2013, Antimicrobial Agents and Chemotherapy.

[43]  R. Bonomo,et al.  OqxAB, a Quinolone and Olaquindox Efflux Pump, Is Widely Distributed among Multidrug-Resistant Klebsiella pneumoniae Isolates of Human Origin , 2013, Antimicrobial Agents and Chemotherapy.

[44]  W. van Schaik,et al.  Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era. , 2013, Current opinion in microbiology.

[45]  Curtis Huttenhower,et al.  Microbial Co-occurrence Relationships in the Human Microbiome , 2012, PLoS Comput. Biol..

[46]  C. Huttenhower,et al.  Metagenomic microbial community profiling using unique clade-specific marker genes , 2012, Nature Methods.

[47]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[48]  R. Xia,et al.  Identification of a novel fosfomycin resistance gene (fosA2) in Enterobacter cloacae from the Salmon River, Canada , 2011, Letters in applied microbiology.

[49]  F. Turroni,et al.  Insights into Physiological and Genetic Mupirocin Susceptibility in Bifidobacteria , 2011, Applied and Environmental Microbiology.

[50]  K. Mathee,et al.  Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[51]  R. Bonomo,et al.  Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. , 2009, The Journal of antimicrobial chemotherapy.

[52]  Nir Friedman,et al.  Probabilistic Graphical Models - Principles and Techniques , 2009 .

[53]  P. Bradford,et al.  RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. , 2007, Microbial drug resistance.

[54]  F. Weill,et al.  Variants of the Klebsiella pneumoniae OKP Chromosomal Beta-Lactamase Are Divided into Two Main Groups, OKP-A and OKP-B , 2005, Antimicrobial Agents and Chemotherapy.

[55]  F. Weill,et al.  Six Groups of the OXY β-Lactamase Evolved over Millions of Years in Klebsiella oxytoca , 2005, Antimicrobial Agents and Chemotherapy.

[56]  M. Pace Bacterial mortality and the fate of bacterial production , 1988, Hydrobiologia.

[57]  Andy B. Yoo,et al.  Approved for Public Release; Further Dissemination Unlimited X-ray Pulse Compression Using Strained Crystals X-ray Pulse Compression Using Strained Crystals , 2002 .

[58]  P. Stewart,et al.  Role of Nutrient Limitation and Stationary-Phase Existence in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin , 2003, Antimicrobial Agents and Chemotherapy.

[59]  N. Wight Donor Human Milk for Preterm Infants , 2001, Journal of Perinatology.

[60]  S. Brisse,et al.  Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. , 2001, International journal of systematic and evolutionary microbiology.

[61]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[62]  Marti J. Anderson,et al.  A new method for non-parametric multivariate analysis of variance in ecology , 2001 .

[63]  G. Drusano,et al.  Meropenem: clinical response in relation to in vitro susceptibility. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[64]  L. Martínez-Martínez,et al.  Identification and Characterization of a New Porin Gene of Klebsiella pneumoniae: Its Role in β-Lactam Antibiotic Resistance , 1999, Journal of bacteriology.

[65]  L. Martínez-Martínez,et al.  Development of Resistance during Antimicrobial Therapy Caused by Insertion Sequence Interruption of Porin Genes , 1999, Antimicrobial Agents and Chemotherapy.

[66]  G. Jacoby,et al.  In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins , 1996, Antimicrobial agents and chemotherapy.

[67]  M. Gilmore,et al.  Virulence of enterococci , 1994, Clinical Microbiology Reviews.

[68]  M. B. Rogers,et al.  Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates , 1994, Journal of bacteriology.

[69]  R. Kolter,et al.  The stationary phase of the bacterial life cycle. , 1993, Annual review of microbiology.

[70]  J. Suárez,et al.  Plasmid-encoded fosfomycin resistance , 1991, Antimicrobial Agents and Chemotherapy.

[71]  Dan Geiger,et al.  d-Separation: From Theorems to Algorithms , 2013, UAI.

[72]  Judea Pearl,et al.  Probabilistic reasoning in intelligent systems - networks of plausible inference , 1991, Morgan Kaufmann series in representation and reasoning.

[73]  G. Donowitz,et al.  Beta-Lactam Antibiotics , 1988 .

[74]  J. Morris,et al.  Outbreak of neonatal Citrobacter diversus meningitis in a suburban hospital , 1987, The Pediatric infectious disease journal.

[75]  A. Tomasz,et al.  Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat , 1986, Antimicrobial Agents and Chemotherapy.

[76]  C. O'callaghan,et al.  beta-lactam antibiotics. , 1979, Giornale italiano di chemioterapia.

[77]  A. Tomasz,et al.  The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. , 1979, Annual review of microbiology.

[78]  G. Churchward,et al.  An examination of the Cooper-Helmstetter theory of DNA replication in bacteria and its underlying assumptions. , 1977, Journal of theoretical biology.

[79]  K. Nordström,et al.  Replication of R-factor R1 in Scherichia coli K-12 at different growth rates , 1975, Journal of bacteriology.